Pathways Involved in the Effect of Eflornithine in Neuroblastoma
J Clin Oncol
.
2024 Jan 1;42(1):116-119.
doi: 10.1200/JCO.23.01783.
Epub 2023 Oct 26.
Authors
Adam J Wolpaw
1
,
Chi V Dang
2
3
4
5
6
Affiliations
1
Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA.
2
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
3
Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD.
4
Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
5
Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD.
6
Ludwig Institute for Cancer Research, New York, NY.
PMID:
37883720
DOI:
10.1200/JCO.23.01783
No abstract available
MeSH terms
Eflornithine*
Humans
Neuroblastoma* / drug therapy
Tretinoin
Substances
Eflornithine
Tretinoin
Grants and funding
R01 CA051497/CA/NCI NIH HHS/United States
R01 CA057341/CA/NCI NIH HHS/United States
R01 CA252225/CA/NCI NIH HHS/United States